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Abstract
Background:  This study used a cross sectional survey to examine the effect of gender, age, and
geographical location on the population prevalence of renal replacement therapy (RRT) provision in
Wales.
Methods: Physicians in renal centres in Wales and in adjacent areas of England were asked to undertake
a census of patients on renal replacement therapy on 30 June 2004 using an agreed protocol. Data were
collated and analysed in anonymous form.
Results: 2434 patients were on RRT in Wales at the census date. Median age of patients on RRT was 56
years, peritoneal dialysis 58 years, haemodialysis 66 years and transplantation 50 years. The three
treatment modalities had significantly different age-specific peak prevalence rates and distributions. RRT
age-specific prevalence rates peaked at around 70 years (1790 pmp), transplantation at around 60 years
(924 pmp), haemodialysis at around 80 years (1080 pmp) and peritoneal dialysis did not have a clear peak
prevalence rate. Age-specific incidence of RRT peaked at a rate of 488 pmp at 79 years, as did incidence
rates for haemodialysis, which peaked at the same age. Age had less effect on the initiation of peritoneal
dialysis, which had a broad plateau between the early fifties and late seventies. Kidney transplantation rates
were highest in the early fifties but were markedly absent in old age.
Conclusion: Differences in the provision of RRT are evident, particularly in the very elderly, where the
gender difference for haemodialysis is particularly marked. The study illustrates that grouping patients over
75 years into a single age-band may mask significant diversity within this age group. Significant numbers of
very elderly patients who are currently not receiving RRT may wish to receive RRT as the elderly
population increases, and as technology improves survival and quality of life on RRT.
The study suggests that if technologies that are more effective were developed, and which had a lower 
impact on quality of life, there might be up to a 17% increase in demand for RRT in those aged over 75 
years; around 90% of this increased demand would be for haemodialysis.
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Background
Since the introduction of renal replacement therapy (RRT)
in the UK in 1946 [1], its use has risen steadily. As survival
has improved, there has been an increasing willingness to
offer dialysis to a wider range of patients including older
patients. This has resulted in rising annual incidence
(acceptance) and prevalence rates. In the 1960s, dialysis
was rarely offered to patients over 65 years[2]. The accept-
ance rate for RRT has steadily risen from around 22 per
million population (pmp) [3] in the UK population in
1982, to 133 pmp in Wales in 2003 [4]. The prevalence
rate has also risen, in England and Wales, from around
393 pmp [5] in 1993 to over 700 pmp [4] in 2003. The
continuing rise in demand for RRT has imposed a huge
strain on resources in renal services [6]. There have been
recurrent demands for yet more investment[7] and some
surprise that demand has not reached a plateau. Geo-
graphical boundaries in Wales have changed and there
was concern to ensure that further investment addressed,
rather than increased, inequalities in gender, age and geo-
graphical location. Some concern had also been expressed
regarding the reliability and independence of available
data. This study attempted to address and explain some of
the issues behind the ongoing requirement for further
investment.
A number of factors underlie the rising demand in RRT.
Technological advances have encouraged the offering of
RRT to older patients with greater co-morbidity. Techno-
logical advances have also improved survival, increasing
the incidence and prevalence of patients on RRT. A rapidly
aging population, has, and will increasingly, exacerbate
the effect of the above factors, as population predictions
suggest that the number of people aged over 60 years will
rise by around 65 per cent over the next 50 years. Simi-
larly, the number of people aged over 75 years is expected
to double, and the number of people aged 90 years and
over is expected to more than triple [8].
Separate analysis of data on RRT prevalence or incidence
in the very elderly has historically been scarce and the use
of summary measures of RRT, encompassing wide age
bands, may also have obscured the underlying shifts in
the numerators and denominators in the elderly. This
study has consequently used age-specific rates, which have
a number of advantages over age-standardised rates as
they are unaffected by differences in demography [9]. This
allows the separating out of age related factors and factors
associated with changes in the provision (demand and
supply) of RRT. Age-standardised rates can only be com-
pared with other age-standardised rates using the same
age-standardised population. For example, age-standard-
ised rates for the UK population cannot be compared with
age-standardised rates for the European population or the
North American population. In contrast, age specific rates
can be compared between any two populations without
being affected by different population pyramids in the dif-
ferent populations [10,11].
Age-specific rates have advantages over age-standardised
rates, particularly for the oldest age band in any analysis.
For example, two identical age-standardised rates for indi-
viduals "over 75 years" could represent two very different
populations. One population where all the population in
this age-band were aged 75–80 years (i.e. had died by the
age of 80 years) and another population where there were
a large proportion of patients living on to 90–100 years
and over. Detailed differences within the age-band "over
75 years" are very relevant to the cost of providing RRT,
given the demographic shift occurring in the western
world. The cost of a patient aged 100 years on RRT is likely
to differ from the cost of treating a patient aged 75 years
because of general frailty and co-morbidity.
A doubling of the number of patients on RRT over, say 80
years or over 90 years will have a major impact on service
provision as these patients are frail and have multiple co-
morbidities. However, because the very elderly make up
only a small proportion of the population, such a rise in
RRT would only result in a small rise in the overall age-
standardised RRT rate for "the over 75 years". The addi-
tional workload for the service is consequently masked.
The similar generation of age-specific rates in other coun-
tries or populations would facilitate debate on the emerg-
ing question as to the true level of unmet need for RRT in
the ninth and tenth decades of life.
Other potential inequalities in RRT provision are also
important to consider. This study has therefore examined
the effect of gender, geographical location and modality
of RRT on RRT prevalence rates. Insufficient numbers were
available to assess the effect of these factors on incidence
rates.
Methods
A census of all patients in Wales on RRT was undertaken
on 30 June 2004. This date was chosen, as it is the middle
day of the year and population projections are calculated
for that day of the year. A protocol was developed with
input from renal physicians and circulated to previously
agreed contacts in all renal centres in Wales and those in
neighbouring areas in England used to treat Welsh
patients. Data gathered included modality of RRT on that
date, postcode, date of birth, gender and an indicator of
whether the patient had first started RRT on or after 1 July
2003.
To comply with data protection legislation, no names or
other personal identifiers were collected. The data were
cleaned by comparing all postcodes with a database of allBMC Nephrology 2007, 8:1 http://www.biomedcentral.com/1471-2369/8/1
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current and past postcodes in Wales and then removing
patients with non-Welsh postcodes. Patients with missing
or invalid postcodes or dates of birth were checked with
the provider Trust. Data sets were combined in a secure
Microsoft Sequel Server 2000 database. Duplicate entries
were identified as those where the date of birth, gender
and postcode were identical. The number of deceased
patients in the collated data set was estimated to ensure
that "ghost" patients would not unduly inflate our RRT
rates.
The study was conducted in conformity with the require-
ments of the Declaration of Helsinki. Advice was sought
from relevant experts to ensure compliance with Data Pro-
tection requirements. The South Wales Renal Managed
Clinical Network determined that formal ethical approval
was not required, as identifiable data was only made avail-
able to Health Solutions Wales staff, who have authorisa-
tion from the Patient Information Advisory Group (PIAG)
to handle Patient Episode Database Wales (PEDW) data
under Section 60 of the Health and Social Care Act 2001.
This view was supported by Health Commission Wales,
an executive agency of the Welsh Assembly Government,
who commissioned the study.
To clean the data set further, possible entries representing
deceased patients were identified by comparing date of
birth, gender and postcode in our data set against the
Welsh NHS Administrative Register (AR) held by Health
Solution Wales. This comparison was made separately for
patients treated by Welsh NHS Trusts and for one English
Trust where there was concern that there might be a signif-
icant number of deceased patients. However, entries
potentially representing deceased patients could not be
removed from the dataset as the matching process could
suggest, but not confirm, that a particular matching entry
might represent a deceased patient. Our methodology was
designed to estimate the potential size of this problem
without having access to NHS numbers and to determine
whether the numbers involved were sufficiently small as
to be ignored in our calculation of RRT rates.
Denominator data were obtained from mid-year esti-
mates of the population of Wales in 2004 (by Local
Health Board) calculated by the Office of National Statis-
tics for each one-year age band from the age of one to 89
years. For the one-year age bands between 90 and 99 years
data from the 2001 census was used, as mid-year estimates
are not available for ages over 89 years. No patients with
an age of over 100 years were identified in the database
and RRT rates for 100 years and over were consequently
set to zero. Rates (pmp) were calculated for each one-year
age band for the three modalities of RRT, i.e. haemodialy-
sis, peritoneal dialysis and transplantation.
Moving averages of 3, 5, 7, 9, 11, 13 and 15 years were
explored using an equal number of years above and below
the age in question. An 11-year moving average was iden-
tified as providing the best balance between retention of
definition of changing features of the graph, minimising
lags in the peaks and troughs in the graph, and yet
smoothing spikes in the data. Data for some graphs were
truncated below 18 yrs and above 90 years because of
numerators of fewer than 5 cases in some of the individ-
ual one-year age bands.
To indicate the probability of being on a given form of
RRT at any given age, the proportion of patients on each
of the three modalities of RRT was calculated for each one-
year age band and converted into a percentage so that the
three percentages came to 100%. An 11-year moving aver-
age was also applied to this data as described above. All
data was analysed and graphed using Microsoft Excel™.
Postcodes were converted into a grid reference and
recorded as an Easting and a Northing. Grid references
were then mapped to Local Health Board (LHB) areas in
Wales. This allowed the calculation of acceptance and
prevalence rates by LHB. 95% confidence intervals were
calculated for these rates using a SQL procedure which
performs the confidence interval algorithm described by
Newcombe[12] and Wilson [13].
Results
Summary measures for the data are shown in Table 1.
There were 63.2% males and 36.8% females, a male to
female RRT ratio of 1.7:1. The median age for patients on
RRT was 56 years, peritoneal dialysis 58 years, haemodial-
ysis 66 years and transplantation 50 years.
The result of our extensive data cleaning and validation
exercise was as follows. The database contained 2434
Table 1: Summary measures for patients on RRT in Wales
RRT Peritoneal Dialysis Haemodialysis Transplantation
Number of patients 2434 299 813 1322
M e d i a n  a g e  ( y e a r s ) 5 65 86 65 0
Mean age (years) 54.70 56.60 62.81 49.44
Standard deviation 16.29 16.51 15.97 14.31BMC Nephrology 2007, 8:1 http://www.biomedcentral.com/1471-2369/8/1
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records with unique dates of birth, which could also be
fully matched to current or historical Welsh postcodes. An
additional 167 records could not be matched to a Welsh
LA area; 110 of these records clearly represented English
postcodes; an additional 35 were probable English post-
codes, and 22 records had invalid postcodes, which could
potentially have been Welsh postcodes. The maximum
number of missing Welsh records in our analysis would
therefore be <1% (22/2434). In conclusion, the 167
unmatched and consequently excluded records identified
during data validation largely represented English and not
Welsh patients and their exclusion would consequently
not have affected our analysis.
Comparison with the Welsh NHS AR indicated that only
10 records (0.45%) represented deceased patients that
had not been removed from the renal registers in various
NHS Trusts. A handful of patients may have been double
counted as a result of errors in dates of birth or postcode
changes. Detailed analysis also suggested that a handful of
errors might also have occurred because patients moved
house during the months preceding the census. Once
again, our data validation indicated that these issues did
not significantly affect our data.
A significant issue was identified in relation to one English
NHS Trust. Comparison between NHS AR data and data
on patients provided with a transplant by this Trust sug-
gested around 3% of the patients still on the trust's renal
register were deceased. These patients were removed from
our database and consequently would not have affected
our results. However, our data validation exercise indi-
cated that other data collection exercises in the UK may
have potentially significant errors due to inadequate
removal of deceased patients from some trust renal regis-
ters.
Age-specific prevalence rates for the three modalities of
RRT had significantly different peak rates and distribu-
tions. RRT age-specific prevalence rates (Figure 1) peaked
at around 70 years with a rate of around 1790 pmp;
haemodialysis age-specific prevalence rates peaked at
around 80 years with a rate of around 1080 pmp; perito-
neal dialysis rates did not have a clear peak; and trans-
plantation age-specific prevalence rates peaked at around
60 years with a rate of around 924 pmp.
Age-specific incidence rates for RRT (Figure 2) peaked at a
rate of around 488 pmp at 79 years. This was very heavily
Age-specific prevalence rates (moving average pmp) of RRT for the renal stock in Wales on 30 June 2004 Figure 1
Age-specific prevalence rates (moving average pmp) of RRT for the renal stock in Wales on 30 June 2004.BMC Nephrology 2007, 8:1 http://www.biomedcentral.com/1471-2369/8/1
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influenced by the high incidence rates for haemodialysis,
which peaked at the same age. Age appears to have much
less effect on initiation of peritoneal dialysis, which had a
broad plateau between the early fifties and late seventies.
Rates of new transplantation were highest in the mid-fif-
ties, but were markedly absent in old age. This is in con-
trast to the renal transplant prevalence rates, which
indicates that a number of patients in old age have func-
tioning transplanted kidneys. These patients appear to
have received their transplants at a much younger age.
Figure 3 explores the relative probability of being on a
given modality of RRT at any given age. The graph indi-
cates that the probability of being on peritoneal dialysis
remains at around 10–15% for all age groups. Until the
age of 60 years the probability of being on haemodialysis
remains at around 25%, after which it rises steeply and
over the age of 80 years an individual on RRT had around
an 80% probability of being on haemodialysis. In con-
trast, the probability of having a transplant falls steadily
from the age of 45 years.
Figure 4 indicates the probability, based on an individ-
ual's age, of commencing a specified modality of RRT
when RRT is first initiated. The graph suggests that physi-
cians prefer giving younger patients renal transplantation
or starting them on peritoneal dialysis. With increasing
age, and particularly after the mid-fifties, physicians
appear to have an increasing preference for starting
patients on haemodialysis. However, some physicians
seem to consider transplantation for occasional patients
up until their late sixties, and some physicians started
patients on dialysis into their late eighties. The extent to
which patients have contributed to these treatment deci-
sions is unclear.
The effect of gender with age is examined in Figure 5. The
graph indicates that at every age, men receive rates of RRT
that are higher, or at least as high, as the rates for women.
This gender difference applies to all three modalities of
RRT. The difference is most marked for transplantation in
middle age and for haemodialysis in old age.
Geographical location also has an effect on RRT rates of
incidence (acceptance) and prevalence (Figures 6 and 7).
North Wales, Swansea, Gwynedd and Wrexham area rates
appear to be higher than the all Wales rates. Cardiff and
Powys area rates appear to be lower than the all Wales
Age-specific incidence rates (moving average pmp) of renal patients alive at the census date and starting RRT in the year prior to  30 June 2004 in Wales Figure 2
Age-specific incidence rates (moving average pmp) of renal patients alive at the census date and starting RRT in the year prior to 
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Age-specific probability (moving average pmp) of being on a given modality of RRT for the renal stock in Wales on 30 June 2004 Figure 3
Age-specific probability (moving average pmp) of being on a given modality of RRT for the renal stock in Wales on 30 June 2004.
Age-specific probability (moving average pmp) of renal patients alive at the census date having started a given modality of RRT in  the year before 30 June 2004 in Wales Figure 4
Age-specific probability (moving average pmp) of renal patients alive at the census date having started a given modality of RRT in 
the year before 30 June 2004 in Wales.BMC Nephrology 2007, 8:1 http://www.biomedcentral.com/1471-2369/8/1
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rates. There is wide variation in the acceptance rate, rang-
ing from under 50 pmp to over 200 pmp.
Geographical location also influences the relative propor-
tion of patients on peritoneal or haemodialysis (Figure 8).
The proportion of patients on haemodialysis in the LHB
areas at the extremes of Figure 8 (Wrexham and Flintshire)
is not statistically significantly different from the propor-
tion of patients on haemodialysis in Wales as a whole
(73.1%). However, there is a 25.1% (95%CI 8.0–40.6%)
difference between the proportions of patients on haemo-
dialysis between these two areas.
Discussion
This study demonstrates significant variation in the provi-
sion of RRT by gender, age, and geographical location.
Differences in RRT rates were most marked by gender and
age, and to a lesser extent by geographical location. Some
of the gender difference in prevalence may be due to risk
factors shared by cardiovascular disease and end stage
renal failure, both of which are commoner in men. How-
ever, some of the gender differences in the very elderly,
particularly the differences in haemodialysis, may be
indicative of underlying inequality in treatment provi-
sion.
Implications for service provision can be drawn from the
findings. Age-specific prevalence for peritoneal dialysis
was relatively similar at all ages, and consequently, perito-
neal dialysis services need to be designed to serve all age
groups in the population. In contrast, support services for
patients with renal transplants needs to be focused on
those under 65 years. For example, attendance at outpa-
tient clinics may significantly interfere with working age
patients who have a transplant.
Patients in Wales under the age of 50 years have a greater
than 50% chance of having a transplant (Figure 3), which
is encouraging for younger patients waiting for a trans-
plant.
The probability of being on peritoneal or haemodialysis
varies depending on the LHB in Wales. This may represent
the preferences of different clinicians for particular treat-
ment modalities, and a wide range of socio-economic
determinants, as well as random chance.
Age-specific prevalence rates (moving average pmp) of RRT for the renal stock in Wales on 30 June 2004 for males and females Figure 5
Age-specific prevalence rates (moving average pmp) of RRT for the renal stock in Wales on 30 June 2004 for males and 
females.BMC Nephrology 2007, 8:1 http://www.biomedcentral.com/1471-2369/8/1
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There are a number of possible reasons why the tertiary
English NHS Trusts, which treat Welsh transplant
patients, might have a higher number of patients recorded
as being alive, when the NHS Administrative Register sug-
gested that they were deceased. Firstly, there may be less
accurate recording of death in this Trust. However, tertiary
care centres may see patients less frequently, if joint care is
undertaken with a locally based clinician. Consequently,
if a patient dies in a local hospital, the tertiary centre may
not be aware of the patient's demise. Our findings suggest
that there is merit in linking databases held by different
Trusts, in forming links between Trust databases, national
renal databases and the NHS AR using patients NHS num-
bers. This would reduce inaccuracies around deceased
patients, patients who have recently moved address, and
patients attending multiple renal centres.
This study suggests that there may be a significant number
of untreated elderly patients with end stage renal failure.
Figure 1 indicates that the rate of RRT provision rises with
age but falls after the mid-seventies. This is unexpected
given the rising trend in morbidity up to this age. The true
underlying rate of end stage renal failure is very unlikely
to fall over the age of 75 years and this suggests that there
may be a gap between need and supply in this very elderly
age group. The discrepancy may be occurring because cli-
nicians and patients are taking into account the personal,
physical, social and psychological costs of treatment, and
the very poor survival curves associated with current treat-
ment over this age, and decide not to offer or accept RRT.
We can provide a crude estimate of the number of poten-
tially untreated patients over the age of 75 years by linear
extrapolation of the population rate for RRT from 1790
pmp at 75 years to 2500 pmp for the age group 100 years.
Similarly, we can extrapolate the haemodialysis rate from
1000 pmp at 85 years to 1500 pmp at 100 years. Extrapo-
lating in this way would suggest that an additional 442
individuals over the age of 75 years might wish to be
treated, if RRT methods were developed that provided
excellent rates of survival and low negative impact on
patients' quality of life. This unmet "need" would repre-
sent a 17% increase on current demand for RRT.
These figures provide a crude estimate of the possible
increase in future demand in the very elderly, without tak-
ing into account other factors such as demographic shift
in the population, or increased provision of RRT to those
Acceptance rates for different LHBs in Wales in the year preceding 30 June 2004 Figure 6
Acceptance rates for different LHBs in Wales in the year preceding 30 June 2004.BMC Nephrology 2007, 8:1 http://www.biomedcentral.com/1471-2369/8/1
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under 75 years. In summary, these findings suggest that,
as RRT technologies continue to improve, an increasing
number of very elderly patients are likely to present for
treatment.
Patients over the age of 75 years have a very high proba-
bility of being on haemodialysis. Population predictions
for the next decade for Wales suggest that this population
group will expand the most. Unless the current treatment
pattern changes significantly, the high use of haemodialy-
sis in old age (Figures 4 &5) combined with the demo-
graphic bulge predicted in this age group suggests that the
demand for haemodialysis in the very elderly will con-
tinue to rise at a higher rate than in younger age groups.
Limitations of this study
Our study has a number of limitations. We have used a
different method of calculating incidence from that used
by the renal registry, which includes patients who started
RRT in the year before the census date, but who also died
in that year. Our figures would, therefore, be expected to
indicate a lower rate than if these patients were included.
Our incidence figures would have been improved if our
data collection had included patients who died in the pre-
ceding year. Our data is cross-sectional: longitudinal data
gives better estimates of incidence, although cross sec-
tional studies such as ours, which ask for changes over the
proceeding year, can be used.
A renal physician from every renal centre in Wales, and
NHS Trusts in England that treat Welsh patients, was used
as a point of contact. Data managers in each trust were
also involved. As each trust keeps a database of patients
receiving treatment for ESRF we were confident that all
individuals receiving treatment had been identified. How-
ever, not all patients with ESRF present for treatment and
not all patients with ESRF are offered or receive treatment.
Prevalence estimates of ESRF based on treatment data-
bases are consequently underestimates of the true preva-
lence.
Based on our discussion with renal physicians in Wales we
are confident that we have identified all patients receiving
treatment by a renal physician. However, very low accept-
ance rates reported in some areas (under 50 pmp) could
Prevalence rates for different LHBs in Wales in the year preceding 30 June 2004 Figure 7
Prevalence rates for different LHBs in Wales in the year preceding 30 June 2004.BMC Nephrology 2007, 8:1 http://www.biomedcentral.com/1471-2369/8/1
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theoretically be the result of local treatment and failure to
refer by non-renal physicians.
Data on ethnicity was not collected in this study, as there
are relatively low rates of non-white populations in most
of Wales. However, this would have provided some useful
additional information as end stage renal failure is
affected by ethnic origin.
The peak rate for a given modality, shown in the graphs
using a moving average, is around two to four years
younger than the true value. This is because the moving
average brings forward the peak in the graphs by between
two to four years when calculated using a 'window' mov-
ing from left to right.
Co-morbidity was not assessed in this study; however, it is
an important factor in the elderly. There is some evidence
that the presence and severity of co-morbid conditions is
more important than age as a predictor of survival after
commencement of dialysis[14,15]. Further information
on the range, variation, severity and relative influence of
co-morbidity on survival would have been informative.
Conservative options have also not been addressed in this
study, but are important to a proportion of patients with
end stage renal failure. There is significant potential for
improved prevention and earlier conservative treatment
to slow deterioration in renal function and affect the
number of patients requiring RRT [16]. A decision not to
offer treatment may also be appropriate [15] although age
alone may sometimes inappropriately be used as a crite-
rion for withholding treatment. In one study, the decision
to withhold dialysis increased at a rate of 12% for every 10
years of increasing age even after adjustment for condi-
tions such as dementia and/or dependency [17].
Comparison with other studies
Most of the significant epidemiological work on renal dis-
ease in the UK has been undertaken by the UK Renal Reg-
istry [4] and its Scottish counterpart [18]. The annual
report of the UK Renal Registry in particular contains
information submitted by all the renal units in Wales and
has expanded year on year. The negative influence of geo-
graphical distance from a renal unit has also previously
been demonstrated in Wales [19]. In Scotland, the effect
of social class [20], co-morbidity [21] and referral patterns
Proportion of patients in different LHBs on peritoneal and haemodialysis in Wales on 30 June 2004 Figure 8
Proportion of patients in different LHBs on peritoneal and haemodialysis in Wales on 30 June 2004.BMC Nephrology 2007, 8:1 http://www.biomedcentral.com/1471-2369/8/1
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of GPs and non-nephrologists [22] have been studied in
detail. Co-morbidity and non-referral are often linked to
age [21,23] but the epidemiological consequences for very
elderly patients has rarely been examined [24].
Conclusion
The study explores the importance of providing RRT rates
for patients over 75 years to more accurately reflect the
rapid changes in RRT provision that are occurring in this
age group. The study identifies variation, and potential
inequality, in the provision of RRT by age, gender and
geographical location. The gender difference in haemodi-
alysis rates in the very elderly is particularly marked and
emphasises the value of calculating age and gender spe-
cific rates of RRT rather than using one combined age-
standardised rate to represent all those over 75 years.
Significant numbers of very elderly patients who are cur-
rently not receiving RRT may wish to have this as the eld-
erly population increases, and as technology improves
survival and quality of life on RRT. The study also suggests
that if technologies that are more effective were devel-
oped, which had a lower impact on quality of life, there
might be up to a 17% increase in demand for RRT in those
aged over 75 years, and given current patterns of treat-
ment, around 90% of this increase in demand would be
for haemodialysis.
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